Eli Lilly pharmaceutical company starts Phase 3 coronavirus trial with drug used to treat arthritis
The first patient has been enrolled in Eli Lilly’s Phase 3 clinical trial to test whether an arthritis drug, baricitinib, marketed as Olumiant, can treat hospitalized COVID-19 patients.
No comments
Post a Comment